OverviewSuggest Edit

CareDx is a global transplant diagnostics company with product offerings of the pre- and post-transplant continuum. It focuses on the discovery, development, and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. It offers the AlloMap, a gene expression testing service that helps clinicians monitor and identify heart transplant recipients with stable graft function who have a low probability of moderate-to-severe acute cellular rejection.

TypePublic
Founded2000
HQBrisbane, CA, US
Websitecaredx.com

Latest Updates

Employees (est.) (Dec 2018)227(+35%)
Revenue (FY, 2020)$192.2 M(+52%)
Share Price (May 2021)$77.7
Cybersecurity ratingAMore

Key People/Management at CareDx

Peter Maag

Peter Maag

Executive Chairman
Chris Cournoyer

Chris Cournoyer

Director
Paul Ciccolella

Paul Ciccolella

Senior Vice President, Global Operations
George Bickerstaff

George Bickerstaff

Director
Fred E. Cohen

Fred E. Cohen

Director
Alexander L. Johnson

Alexander L. Johnson

Senior Vice President, Products, Cell Therapy & Business Development
Show more

CareDx Office Locations

CareDx has offices in Brisbane, South San Francisco, West Chester, Fremantle and in 2 other locations
Brisbane, CA, US (HQ)
3260 Bayshore Blvd
South San Francisco, CA, US
1 Tower Pl 9th floor
West Chester, PA, US
901 S Bolmar St suite r
Fremantle, AU
20 Collie St
Wien, AT
Löwengasse 47/00
Stockholm, SE
Franzéngatan 5
Show all (6)

CareDx Financials and Metrics

CareDx Revenue

CareDx's revenue was reported to be $192.19 m in FY, 2020
USD

Revenue (FY, 2020)

192.2m

Net income (FY, 2020)

(18.7m)

EBIT (FY, 2020)

(22.5m)

Market capitalization (7-May-2021)

4.0b

Closing stock price (7-May-2021)

77.7

Cash (31-Dec-2020)

134.7m

EV

3.9b
CareDx's current market capitalization is $4 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

27.3m28.1m40.6m48.3m76.6m127.1m192.2m

Revenue growth, %

3%44%

Cost of goods sold

8.5m10.3m10.2m9.0m45.5m

Gross profit

18.8m17.9m30.4m39.3m81.6m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

6.8m6.7m7.2m7.1m7.2m6.6m10.7m12.5m11.6m12.0m12.2m14.1m17.8m21.2m26.0m31.5m28.2m38.4m36.3m45.5m

Cost of goods sold

2.4m1.8m2.7m2.5m2.6m2.8m3.1m3.4m2.3m2.2m2.1m2.3m11.5m12.4m11.9m

Gross profit

4.4m4.9m4.5m4.6m4.6m3.8m7.7m9.1m9.3m9.9m10.1m11.8m19.9m26.0m33.6m

Gross profit Margin, %

65%73%62%65%64%58%72%73%80%82%83%84%63%68%74%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

36.4m29.9m17.3m16.9m64.6m38.2m134.7m

Accounts Receivable

2.7m2.4m2.8m3.0m9.8m24.1m34.6m

Prepaid Expenses

1.4m1.8m3.6m3.8m

Inventories

686.0k766.0k5.5m5.5m4.9m6.0m10.0m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

781.0k(13.7m)(39.8m)(55.6m)(46.8m)(22.0m)(18.7m)

Depreciation and Amortization

512.0k796.0k2.9m3.8m4.2m5.5m7.0m

Inventories

(168.0k)(80.0k)492.0k1.0m363.0k(1.3m)(3.2m)

Accounts Payable

510.0k489.0k(620.0k)292.0k(168.0k)1.4m4.4m
USDQ2, 2014

Debt/Equity

-0.1 x

Debt/Assets

0.2 x

Financial Leverage

-0.2 x
Show all financial metrics

CareDx Acquisitions / Subsidiaries

Company NameDateDeal Size
XynManagementAugust 29, 2019

CareDx Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

CareDx Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

CareDx Online and Social Media Presence

Embed Graph

CareDx News and Updates

CareDx to Present New Heart Transplant Data at the International Society for Heart and Lung Transplantation Annual Meeting

Renowned transplant clinicians to present 15 heart abstracts at ISHLT Renowned transplant clinicians to present 15 heart abstracts at ISHLT

CareDx to Debut Multicenter Data on AlloSure® Lung, an Analytically and Clinically Validated Biomarker of Graft Injury for Lung Transplant Patients

Leading transplant clinicians to present data in seven abstracts at International Society of Heart and Lung Transplantation Annual Meeting Leading transplant clinicians to present data in seven abstracts at International Society of Heart and Lung Transplantation Annual Meeting

CareDx Showcases Transplantation Innovation and Leadership in Europe at EFI 2021

Virtual Events to Highlight New Data and AlloSeq Solutions for European Labs and Clinicians Virtual Events to Highlight New Data and AlloSeq Solutions for European Labs and Clinicians

CareDx to Present at UNOS Transplant Management Forum

Company to showcase its latest integrated solutions for improving care across the whole transplant journey Company to showcase its latest integrated solutions for improving care across the whole transplant journey

CareDx Announces New HLA Typing Service Offering for Research Purposes

Initial projects underway for global pharmaceutical company Initial projects underway for global pharmaceutical company

CareDx to Participate in National Kidney Foundation 2021 Spring Clinical Meetings

CareDx to Host Virtual Exhibitor Showcase and Continuing Medical Education Program CareDx to Host Virtual Exhibitor Showcase and Continuing Medical Education Program
Show more

CareDx Blogs

CareDx Reports First Quarter 2021 Results

CareDx Reports First Quarter 2021 Results Content Import Wed, 05/05/2021 - 16:01 CareDx Reports First Quarter 2021 Results May 05, 2021 This release is a backfill from a News Wire General Releases General …

Palmetto MolDx Issues Foundational Coverage for Molecular Testing in Solid Organ Allograft Rejection

Current Medicare coverage for CareDx services remains unchanged under the new universal coverage policy SOUTH SAN FRANCISCO, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of

CareDx to Report First Quarter 2021 Financial Results

CareDx to Report First Quarter 2021 Financial Results Content Import Wed, 04/21/2021 - 16:00 CareDx to Report First Quarter 2021 Financial Results Apr 21, 2021 This release is a backfill from a News Wire General Releases …

How Common is Cancer in Organ Transplant Recipients?

As an organ transplant recipient, you already “know” several things: You know what the anxiety and stress of end-stage organ disease feels like You know that your life has been improved after receiving your transplant You know that by taking care of your transplant, you can reduce the risk of reject…

The ‘Heart’ of the Matter is That an Organ Donation Saved Sam Dey’s Life

In 2009, Sam Dey was working for General Motors and in India on business. It was during that business trip that Sam started falling. “I was collapsing and falling in these incredibly crowded streets of India,” says Sam. “I was falling everywhere, and people were always pouring water on my face to re…

Common Signs & Symptoms That Your Body is Rejecting Your Transplanted Kidney or Heart

A person living with a transplanted organ can live a healthy and normal life. However, to increase your chances of long-term success, experts say that immunosuppressants (anti-rejection medications) must be taken every day as directed.1 “A transplanted organ is seen as a foreign object—or an ‘unwelc…
Show more

CareDx Frequently Asked Questions

  • When was CareDx founded?

    CareDx was founded in 2000.

  • Who are CareDx key executives?

    CareDx's key executives are Peter Maag, Chris Cournoyer and Paul Ciccolella.

  • How many employees does CareDx have?

    CareDx has 227 employees.

  • What is CareDx revenue?

    Latest CareDx annual revenue is $192.2 m.

  • What is CareDx revenue per employee?

    Latest CareDx revenue per employee is $846.7 k.

  • Who are CareDx competitors?

    Competitors of CareDx include Kewaunee, Diesse Diagnostica Senese and Inform Diagnostics.

  • Where is CareDx headquarters?

    CareDx headquarters is located at 3260 Bayshore Blvd, Brisbane.

  • Where are CareDx offices?

    CareDx has offices in Brisbane, South San Francisco, West Chester, Fremantle and in 2 other locations.

  • How many offices does CareDx have?

    CareDx has 6 offices.